Skip to content

DEN ELS

Active
Private limited companyfounded 2009active for 17 yearsHoornveldstraat 2C, 2520 Ranst, BelgiumKBO/BCE: BE 0809.956.136
Summary

DEN ELS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€31,279) and a net result of €19,142. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 5% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €140,000turnover 2025, estimated
Equity
-€31,279
Profit
€19,142
Turnover estimated from the gross margin
Financial health
55 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Largest shareholder
DOKTER VAN ELSEN PHILIPPE · 33.33%
2025 accounts 58 days early1 of 2 deeds summarised
Why 55raises riskCapped at 59: negative equityNegative equity -€31,279lowers riskSector: Human health activities (NACE 86)Size: total assets €290,695Liquidity: current ratio 3.11, cash €170,304Show the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 45% of its sector peers (NACE 86, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 14+4
equity -10.8% of total assets
Liquidity 94-1
short-term debt 19.8% · cash 58.6%
Profitability 77+2
return on assets 6.6%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
No credit on open account
Liquidity ample (current ratio 3.11, compared with 3.16 in 2024, above the usual 1.5; short-term debt: 19.8% and cash: 58.6% of total assets), but equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 3% on solvency, 80% on liquidity, 21% on profitability and 76% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Negative equity -€31,279
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €290,695
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 3.11, cash €170,304
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20620 sector peers (2025).
NBB · sector comparison
Position among 20620 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
58 days early
2024
51 days early
2023
48 days early
2022
21 days late
2021
5 days early
2020
30 days late
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 June (4 of the last 5 filed years within 42 days of that day).
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Financials · financial year 2025, micro format

Turnover
≈ €140,000
Estimated: probably between €110,000 and €180,000
Total assets
€290,695▼ 11.5%
2024 · €328,536
Net result
€19,142▲ 24.8%
2024 · €15,338
Working capital
€121,802▼ 0.9%
2024 · €122,959
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result recovers in 2025; 2025 is 14% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€24,589 2025 Net result€19,142 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€5,904-€11,544▲ 95.5%-€15,478€10,417€60,546▲ 481%€35,723▼ 41.0%€21,610▼ 39.5%€24,589▲ 13.8%
Net result-€4,924-€1,307-€24,936below the sector's middle half€1,734below the sector's middle half€52,445within the sector's middle half▲ 30×€28,468below the sector's middle half▼ 45.7%€15,338below the sector's middle half▼ 46.1%€19,142below the sector's middle half▲ 24.8%
Equity-€124,776--€123,469▲ 1.0%-€148,405below the sector's middle half▼ 20.2%-€146,671below the sector's middle half▲ 1.2%-€94,226below the sector's middle half▲ 35.8%-€65,759below the sector's middle half▲ 30.2%-€50,421below the sector's middle half▲ 23.3%-€31,279below the sector's middle half▲ 38.0%
Total assets€594,210-€545,860▼ 8.1%€463,450within the sector's middle half▼ 15.1%€415,516below the sector's middle half▼ 10.3%€416,173below the sector's middle half▲ 0.2%€369,317below the sector's middle half▼ 11.3%€328,536below the sector's middle half▼ 11.0%€290,695within the sector's middle half▼ 11.5%
Debt€718,986-€669,329▼ 6.9%€611,856▼ 8.6%€562,187▼ 8.1%€510,399▼ 9.2%€435,076▼ 14.8%€378,957▼ 12.9%€321,974▼ 15.0%
Working capital€51,885-€40,106▼ 22.7%€17,866below the sector's middle half▼ 55.5%€17,096below the sector's middle half▼ 4.3%€62,450within the sector's middle half▲ 265%€127,109within the sector's middle half▲ 104%€122,959within the sector's middle half▼ 3.3%€121,802within the sector's middle half▼ 0.9%
Solvency-21.0%--22.6%▼ 1.6pp-32.0%below the sector's middle half▼ 9.4pp-35.3%below the sector's middle half▼ 3.3pp-22.6%below the sector's middle half▲ 12.7pp-17.8%below the sector's middle half▲ 4.8pp-15.3%below the sector's middle half▲ 2.5pp-10.8%below the sector's middle half▲ 4.6pp
Current ratio1.82-1.60▼ 0.221.29below the sector's middle half▼ 0.321.25below the sector's middle half▼ 0.041.86within the sector's middle half▲ 0.613.26within the sector's middle half▲ 1.403.16within the sector's middle half▼ 0.103.11within the sector's middle half▼ 0.04
Return on assets (ROA)-0.8%-0.2%▲ 1.1pp-5.4%below the sector's middle half▼ 5.6pp0.4%below the sector's middle half▲ 5.8pp12.6%within the sector's middle half▲ 12.2pp7.7%within the sector's middle half▼ 4.9pp4.7%below the sector's middle half▼ 3.0pp6.6%below the sector's middle half▲ 1.9pp
Staff (FTE)1.3-1.6▲ 23.1%1.5within the sector's middle half▼ 6.3%1.4within the sector's middle half▼ 6.7%1.3within the sector's middle half▼ 7.1%0below the sector's middle half▼ 100%
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €290,695
Fixed assets €111,299 ▼ 25.1%
Current assets €179,396 ▼ 0.3%
Equity and liabilities
Equity-€31,279
Debt€321,974
Equity is negative: debt (€321,974) exceeds the balance-sheet total (€290,695).
Key figures and ratios
2025 value · change against 2024
EBITDA
€61,884▲
2024 · €58,906
Cash flow
€56,438▲
2024 · €52,633
Interest coverage
11.36▲
2024 · 9.39
Debt ≤ 1 year
€57,594▲
2024 · €56,983
Debt > 1 year
€264,380▼
2024 · €321,974
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,632 companies that looked in July 2024 the way this one looks now, 2.9% went bankrupt within 24 months and 91.9% are still going.

  • Micro
  • 10 to 20 years old
  • negative equity
  • a profit of 5% of the balance sheet or more
2.9% went bankrupt
4.8% stopped otherwise
91.9% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,632 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 30 lines
Balance sheet Code20242025
Assets
Total assets20/58€328,536€290,695▼
Fixed assets21/28€148,595€111,299▼
Tangible fixed assets22/27€148,595€111,299▼
Land and buildings22€148,595€111,299▼
Current assets29/58€179,941€179,396▼
Amounts receivable within one year40/41€9,093€9,093=
Trade receivables40€9,093€9,093=
Cash at bank and in hand54/58€170,849€170,304▼
Equity and liabilities
Total equity and liabilities10/49€328,536€290,695▼
Equity10/15-€50,421-€31,279▲
Contributions10/11€18,600€18,600=
Profit (loss) carried forward14-€69,021-€49,879▲
Amounts payable17/49€378,957€321,974▼
Amounts payable after more than one year17€321,974€264,380▼
Financial debts170/4€321,974€264,380▼
Amounts payable within one year42/48€56,983€57,594▲
Current portion of amounts payable after more than one year42€56,783€57,594▲
Trade debts44€200€0▼
Suppliers440/4€200€0▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€37,296€37,296=
Other operating charges640/8€2,560€2,534▼
Gross operating margin9900€61,466€64,419▲
Operating profit (loss)9901€21,610€24,589▲
Financial charges65/66B€6,273€5,446▼
Recurring financial charges65€6,273€5,446▼
Profit (loss) for the period before taxes9903€15,338€19,142▲
Profit (loss) for the period9904€15,338€19,142▲
Profit (loss) for the period to be appropriated9905€15,338€19,142▲
Appropriation of the result
Profit (loss) to be appropriated9906-€69,021-€49,879▲
Profit (loss) brought forward from the previous period14P-€84,359-€69,021▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€64,029€57,977€0---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€56,178€60,752€56,341€53,477€46,866€37,341€37,296€37,296=
Other operating charges640/8---€2,663€3,484€2,542€2,560€2,534▼ 1.0%
Gross operating margin9900€125,135€131,790€114,350€130,585€168,874€75,606€61,466€64,419▲ 4.8%
Operating profit (loss)9901€5,904€11,544-€15,478€10,417€60,546€35,723€21,610€24,589▲ 13.8%
Financial income75/76B---€5-----
Recurring financial income75-€0€0€5-----
Financial charges65/66B---€8,688€8,101€7,255€6,273€5,446▼ 13.2%
Recurring financial charges65€10,828€10,237€9,458€8,688€8,101€7,255€6,273€5,446▼ 13.2%
Profit (loss) for the period before taxes9903-€4,924€1,307-€24,936€1,734€52,445€28,468€15,338€19,142▲ 24.8%
Profit (loss) for the period9904-€4,924€1,307-€24,936€1,734€52,445€28,468€15,338€19,142▲ 24.8%
Profit (loss) for the period to be appropriated9905-€4,924€1,307-€24,936€1,734€52,445€28,468€15,338€19,142▲ 24.8%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€594,210€545,860€463,450€415,516€416,173€369,317€328,536€290,695▼ 11.5%
Fixed assets21/28€479,054€439,288€382,948€329,471€281,174€185,890€148,595€111,299▼ 25.1%
Intangible fixed assets21€307€1,936€1,452€968-----
Tangible fixed assets22/27€478,746€437,352€381,496€328,503€281,174€185,890€148,595€111,299▼ 25.1%
Land and buildings22---€53,333€45,249€185,890€148,595€111,299▼ 25.1%
Furniture and vehicles24---€463-----
Leasing and similar rights25---€274,707€235,925€0---
Current assets29/58€115,157€106,572€80,503€86,045€134,999€183,427€179,941€179,396▼ 0.3%
Amounts receivable within one year40/41€9,331€12,868€9,157€9,157€9,157€20,204€9,093€9,093=
Trade receivables40---€9,093€9,093€20,204€9,093€9,093=
Other amounts receivable41---€64€64€0---
Cash at bank and in hand54/58€103,306€89,385€69,243€38,401€92,127€163,223€170,849€170,304▼ 0.3%
Deferred charges and accrued income490/1---€38,487€33,715€0---
Equity and liabilities
Total equity and liabilities10/49€594,210€545,860€463,450€415,516€416,173€369,317€328,536€290,695▼ 11.5%
Equity10/15-€124,776-€123,469-€148,405-€146,671-€94,226-€65,759-€50,421-€31,279▲ 38.0%
Contributions10/11€18,600€18,600€18,600€18,600€18,600€18,600€18,600€18,600=
Capital10---€18,600€18,600----
Issued capital100---€18,600€18,600----
Profit (loss) carried forward14-€143,376-€142,069-€167,005-€165,271-€112,826-€84,359-€69,021-€49,879▲ 27.7%
Amounts payable17/49€718,986€669,329€611,856€562,187€510,399€435,076€378,957€321,974▼ 15.0%
Amounts payable after more than one year17€650,898€598,003€544,353€489,935€434,740€378,757€321,974€264,380▼ 17.9%
Financial debts170/4---€489,935€434,740€378,757€321,974€264,380▼ 17.9%
Amounts payable within one year42/48€63,271€66,466€62,637€68,949€72,549€56,319€56,983€57,594▲ 1.1%
Current portion of amounts payable after more than one year42---€54,417€55,195€55,983€56,783€57,594▲ 1.4%
Trade debts44€4,010€3,618€4,582€5,784€12,121€335€200€0▼ 100%
Suppliers440/4---€5,784€12,121€335€200€0▼ 100%
Taxes, remuneration and social security45---€4,343€5,233€0---
Remuneration and social security454/9---€4,343€5,233€0---
Other amounts payable47/48---€4,404-----
Accrued charges and deferred income492/3---€3,304€3,110€0---
Line20182019202020212022202320242025Change
Profit (loss) for the period9904-€4,924€1,307-€24,936€1,734€52,445€28,468€15,338€19,142▲ 24.8%
+ Depreciation and write-downs630€56,178€60,752€56,341€53,477€46,866€37,341€37,296€37,296=
Operating cash flow (approximation)€51,254€62,058€31,405€55,210€99,311€65,809€52,633€56,438▲ 7.2%
Investment in fixed assets (approximation)--€20,986€0€0€1,431€57,942€0€0-
Change in cash--€13,921-€20,142-€30,841€53,726€71,096€7,625-€545-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 16 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 03-06-2026 2026-00135264
31-12-2024 abbreviated format 10-06-2025 2025-00129041
31-12-2023 abbreviated format 13-06-2024 2024-00131090
31-12-2022 abbreviated format 21-08-2023 2023-00340239
31-12-2021 abbreviated format 26-07-2022 2022-20231385
31-12-2020 abbreviated format 30-08-2021 2021-57000206
31-12-2019 micro format 28-08-2020 2020-46400359
31-12-2018 micro format 08-07-2019 2019-29900466
31-12-2017 micro format 20-08-2018 2018-47300462
31-12-2016 micro format 24-08-2017 2017-48300072

Show all 16 filings

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 16,581 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,120. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
2 directors, last change in 2023
PILAET Ann Sarah Betina
Director (not named in the articles)
Current
VAN ELSEN Philippe Louis Seraphine
Director (not named in the articles)
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 2 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

3 people since 2023, 2 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
PILAET Ann Sarah Betina
  • Director (not named in the articles), since before 02-10-2023
VAN ELSEN Philippe Louis Seraphine
  • Director (not named in the articles), since before 02-10-2023
BREESCH Riet Angèle Lieve
  • Director, until 02-10-2023
See the board, name and registered office on a given date →

Owners and capital

Owners

1 owner

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Capital over the years
  1. 02-10-2023 Converted to unavailable equity · €18,600

Group and network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

DEN ELS was incorporated on 20 February 2009.1 Total assets fell from €594,210 in 2018 to €290,695 in 2025 and headcount from 1.3 full-time equivalents in 2018 to 1.3 in 2022.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018, 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
03-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
10-06
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
13-06
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
2023
02-10
Gazette deed Resignation: BREESCH Riet Angèle Lieve (director)
Reappointments: VAN ELSEN Philippe Louis Seraphine (director) and PILAET Ann Sarah Betina (director) · Amendment of the articles · Legal-form conversion17 facts ▸
  • General meeting, 25-09-2023
  • Amendment of the articles
  • Legal-form conversion, “besloten vennootschap” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffen en beschikbaar maken voor uitkering, statutair onbeschikbare eigen vermogensrekening aangelegd bij toepassing artikel 39,§2,tweede lid wet 23 maart 201…” (deed in Dutch)
  • Other provision, “éénparigheid van stemmen, beëindiging uitoefening beroep van arts” (deed in Dutch)
  • Purpose change
  • Transfer restriction, “éénparigheid van stemmen, helft overdrager en helft koper(s) naar evenredigheid verworven aantal,ook bij weigering erfgenaam of legataris” (deed in Dutch)
  • Other provision, “éénparigheid van stemmen, invoering schriftelijke en elektronische algemene vergadering” (deed in Dutch)
  • General meeting, “als gevolg van de voorgaande beslissingen” (deed in Dutch)
  • Name clause, DEN ELS
  • Capital
  • +5 further facts in this act
21-08
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 21 days late
2022
31-12
Financial Highest result from 2018 to 2025net €52,445 ▲2,925%
Operating result €60,546, net result €52,445, both a record.
26-07
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial Back to profitnet €1,734
Net result €1,734 after one loss-making year.
30-08
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 30 days late
2020
31-12
Financial Weakest financial yearnet -€24,936
Net result drops to -€24,936, the lowest in the series; recovery starts the following year.
28-08
NBB filing Annual accounts filed
financial year 2019 · micro format · 28 days late
2019
31-12
Financial Back to profitnet €1,307
Net result €1,307 after one loss-making year.
Show earlier events
08-07
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
20-08
NBB filing Annual accounts filed
financial year 2017 · micro format · 20 days late
2017
24-08
NBB filing Annual accounts filed
financial year 2016 · micro format · 24 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all 16 are under Financials.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded20-02-2009
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
85599Other education
96999Other personal services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0809956136
Also 9925:BE0809956136
Registered 27-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Ranst · 1 establishment unit since 2009
registered office establishment The establishment unit on the map
Ground area
5,629 m²
Building footprint
402 m²
Parcel 11031C0501/00Z002, Flanders. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
DEN ELS
Hoornveldstraat 2C, 2520 RanstBuying and selling of own real estate
since 2009unit no. 2.178.617.327
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
11031C0501/00Z002 Flanders 5,629 m² 1 · 402 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Het aanleggen, het oordeelkundig uitbouwen en het beheren van een onroerend vermogen; alle verrichtingen met betrekking tot onroerende…” (deed in Dutch)
9 activities (deed in Dutch)
  1. Het aanleggen, het oordeelkundig uitbouwen en het beheren van een onroerend vermogen; alle verrichtingen met betrekking tot onroerende goederen of zakelijke rechten daarop, in België of in het buitenland, zoals de aan- en verkoop, de bouw, de verbouwing, de binnenhuisinrichting en decoratie, de huur en verhuur, de ruil, de verkaveling en in het algemeen alle verrichtingen die rechtstreeks of onrechtstreeks betrekking hebben op het beheer of op het productief maken van onroerende goederen of onroerende zakelijke rechten;
  2. Het aanleggen, het oordeelkundig uitbouwen en het beheren van een roerend vermogen; alle verrichtingen met betrekking tot roerende goederen en rechten, van welke aard, zoals de aan- en verkoop, de huur en verhuur, de ruil; in het bijzonder het beheer en de valorisatie van alle verhandelbare waardepapieren, aandelen, obligaties, staatsfondsen, en dergelijke;
  3. Het verwerven en aanhouden van participaties, in eender welke vorm, in alle bestaande of op te richten industriële, commerciële, financiële, vennootschappen of ondernemingen, alsook in alle landbouw- of immobiliënvennootschappen of ondernemingen; het stimuleren, de planning en coördinatie van de ontwikkeling van de vennootschappen en ondernemingen waarin ze een participatie aanhoudt; het deelnemen aan hun beheer, bestuur, vereffening en toezicht alsmede het verlenen van technische, administratieve en financiële bijstand aan deze vennootschappen en ondernemingen;
  4. Het deelnemen aan het beheer, het bestuur, de vereffening en het toezicht, alsmede het verlenen van technische, administratieve en financiële bijstand aan alle mogelijke vennootschappen en ondernemingen;
  5. Het verlenen van bijstand, advies en leiding aan bedrijven, privé-personen en instellingen, voornamelijk doch niet uitsluitend op het vlak van management, administratie, marketing, productie en ontwikkeling, processing en het besturen van vennootschappen, dit alles in de meest ruime betekenis;
  6. Het toestaan van leningen, kredietopeningen, kasvoorschotten aan derden en het optreden als tussenpersoon voor spaar- en beleggingsproducten, alsmede het verlenen van adviezen voor beleggingen (gereglementeerde bankfuncties of spaarkasfuncties niet inbegrepen);
  7. Het optreden als gevolmachtigde van derden;
  8. Het verlenen van borgstellingen in voordeel van derden, hierin begrepen rechtspersonen;
  9. Optreden als makelaar en/of agent voor/van alle verzekeringsmaatschappijen.

The full purpose is in the deed

Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, besluit van het bestuursorgaan” (deed in Dutch)

deed of 02-10-2023

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Voor de duur van haar bestaan, 1” (deed in Dutch)
“Ten laste van algemene kosten, algemene vergadering” (deed in Dutch)
Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
One provision in the deed

deed of 02-10-2023

Capital, shares and profit

Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Overdracht onder levenden, overdracht aandelen-goedkeuring” (deed in Dutch)

deed of 02-10-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Last Friday of May at 19:00

deed of 02-10-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Vormen vereist voor statutenwijziging, op elk moment” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Bij ontbinding om welke reden en op welk ogenblik ook, bevoegdheden en vergoeding” (deed in Dutch)

deed of 02-10-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Elektronische algemene vergadering-deelname op afstand, door de vennootschap ter beschikking gesteld elektronisch communicatiemiddel” (deed in Dutch)
Other provision: “Voorkeurrecht nieuwe aandelen tegen geld, eerst aan andere aandeelhouders die voorkeurrecht volledig uitoefenden,herhaald tot volledig…” (deed in Dutch)
Other provision: “Op naam, aandelen op naam en register” (deed in Dutch)
Other provision: “Toezicht, kan zich laten bijstaan door accountant” (deed in Dutch)
Other provision: “Geheel of gedeelte van zijn aandelen, overdracht door enige aandeelhouder” (deed in Dutch)
Other provision: “Later uit te voeren stortingen op in speciën onderschreven niet geheel volgestorte aandelen, stortingen door enige aandeelhouder-bestuurder” (deed in Dutch)
Other provision: “Tegenstrijdig belang enige aandeelhouder-enige bestuurder, verrichting met tegenstrijdig belang zoals bedoeld in artikel 5:76 en volgende…” (deed in Dutch)
Other provision: “Enige aandeelhouder, bevoegdheden en vergadering enige aandeelhouder” (deed in Dutch)
Other provision: “Dagvaardingen,betekeningen,kennisgevingen betreffende zaken vennootschap, keuze van woonplaats” (deed in Dutch)
11 more provisions in the deed, see the deed of 02-10-2023

deed of 02-10-2023